Assessing the potential for drug-drug interactions in an accelerated throughout mode

Pharmaceutical Science and Technology Today

Volumn 2, Issue 3, 1999, Pages 119-120

  Crespi, Charles L ^a  

^a Gentest Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG SCREENING; ENZYME INHIBITION; REVIEW;

EID: 0033105960     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00127-3     Document Type: Review

References (11)

1. Guengerich F.P. Li A.P. Drug-Drug Interactions: Scientific and Regulatory Perspectives. 1997;7-35 Academic Press.
2. Nelson D.R.et al. Pharmacogenetics. 6:1996;1-42.
3. Mullins M.E.et al. J. Am. Med. Assoc. 280:1998;157-158.
4. Wynalda M.A.et al. Drug Metab. Dispos. 25:1997;1211-1214.
5. Rodrigues A.D.et al. Anal. Biochem. 219:1994;309-320.
6. Rodrigues A.D.et al. Drug Metab. Dispos. 24:1996;126-136.
7. Rodrigues A.D.et al. Drug Metab. Dispos. 25:1997;1097-1100.
8. Crespi C.L.et al. Anal. Biochem. 248:1997;188-190.
9. Miller V.P.et al. Int. Symp. Microsomes Drug Oxid 12:1998;325.
10. Palamanda J.R.et al. Drug Discovery Today. 3:1998;466-470.
11. Korzekwa K.R.et al. Biochemistry. 37:1998;4137-4138.